Xiangxue Pharmaceutical Cash Flow Conversion Efficiency

Latest as of September 2025: 0.069x

Xiangxue Pharmaceutical cash flow conversion efficiency. Based on the latest financial reports, Xiangxue Pharmaceutical (300147) has a cash flow conversion efficiency ratio of 0.069x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥75.64 Million ≈ $11.07 Million USD) by net assets (CN¥1.10 Billion ≈ $160.78 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Xiangxue Pharmaceutical (2007–2025)

Cash flow conversion efficiency of Xiangxue Pharmaceutical from 2007 to 2025. This chart illustrates how Xiangxue Pharmaceutical's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 300147 live share price for real-time trading data and today's change.

Xiangxue Pharmaceutical Cash Flow Conversion Ratio Explained

Xiangxue Pharmaceutical cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Xiangxue Pharmaceutical Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Xiangxue Pharmaceutical ranked by their cash flow conversion efficiency. Also see how much is Xiangxue Pharmaceutical worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Tianjin Tianbao Infrastructure Co Ltd SHE:000965	0.025x
Ningbo Daye Garden Machinery Co Ltd SHE:300879	-0.191x
Lake Materials Co. Ltd. KQ:281740	0.006x
Cachet Pharmaceutical Co Ltd SHE:002462	0.078x
Coca-Cola Europacific Partners PLC LSE:CCEP	0.105x
Tongqinglou Dining Co Ltd SHG:605108	N/A
Movida Participações S.A SA:MOVI3	-0.100x
ICRA Limited NSE:ICRA	0.071x

Annual Cash Flow Conversion Efficiency for Xiangxue Pharmaceutical (2007–2025)

The table below shows the annual cash flow conversion efficiency of Xiangxue Pharmaceutical from 2007 to 2025. Review 300147 FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥43.95 Million ≈ $6.43 Million	CN¥139.63 Million ≈ $20.43 Million	3.177x	+25054.40%
2024-12-31	CN¥1.44 Billion ≈ $210.55 Million	CN¥18.17 Million ≈ $2.66 Million	0.013x	-88.91%
2023-12-31	CN¥2.31 Billion ≈ $338.50 Million	CN¥263.44 Million ≈ $38.55 Million	0.114x	+41.15%
2022-12-31	CN¥2.82 Billion ≈ $412.39 Million	CN¥227.38 Million ≈ $33.27 Million	0.081x	+17.71%
2021-12-31	CN¥3.76 Billion ≈ $549.88 Million	CN¥257.56 Million ≈ $37.69 Million	0.069x	+13.35%
2020-12-31	CN¥4.25 Billion ≈ $622.35 Million	CN¥257.18 Million ≈ $37.63 Million	0.060x	+199.49%
2019-12-31	CN¥4.11 Billion ≈ $601.66 Million	CN¥83.02 Million ≈ $12.15 Million	0.020x	-11.21%
2018-12-31	CN¥4.01 Billion ≈ $587.12 Million	CN¥91.24 Million ≈ $13.35 Million	0.023x	-19.37%
2017-12-31	CN¥3.88 Billion ≈ $568.31 Million	CN¥109.53 Million ≈ $16.03 Million	0.028x	-47.65%
2016-12-31	CN¥3.68 Billion ≈ $539.14 Million	CN¥198.48 Million ≈ $29.04 Million	0.054x	+19.47%
2015-12-31	CN¥3.55 Billion ≈ $518.89 Million	CN¥159.89 Million ≈ $23.40 Million	0.045x	-49.04%
2014-12-31	CN¥1.87 Billion ≈ $273.82 Million	CN¥165.58 Million ≈ $24.23 Million	0.088x	-53.92%
2013-12-31	CN¥1.71 Billion ≈ $250.23 Million	CN¥328.37 Million ≈ $48.05 Million	0.192x	+148.14%
2012-12-31	CN¥1.54 Billion ≈ $224.85 Million	CN¥118.91 Million ≈ $17.40 Million	0.077x	+271.56%
2011-12-31	CN¥1.42 Billion ≈ $207.64 Million	CN¥29.55 Million ≈ $4.32 Million	0.021x	-37.21%
2010-12-31	CN¥1.37 Billion ≈ $200.56 Million	CN¥45.47 Million ≈ $6.65 Million	0.033x	-75.75%
2009-12-31	CN¥337.62 Million ≈ $49.41 Million	CN¥46.19 Million ≈ $6.76 Million	0.137x	-51.75%
2008-12-31	CN¥196.54 Million ≈ $28.76 Million	CN¥55.72 Million ≈ $8.15 Million	0.284x	-60.67%
2007-12-31	CN¥191.45 Million ≈ $28.02 Million	CN¥138.02 Million ≈ $20.20 Million	0.721x	--

About Xiangxue Pharmaceutical

SHE:300147 China Biotechnology

Market Cap

$469.31 Million

CN¥3.21 Billion CNY

Market Cap Rank

#12282 Global

#3583 in China

Share Price

CN¥4.85

Change (1 day)

+11.49%

52-Week Range

CN¥4.07 - CN¥10.99

All Time High

CN¥25.81